You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

POLE exonuclease domain mutant

Showing 1 - 25 of 1,459
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

POLE Exonuclease Mutant Colon Cancer, Microsatellite Instability, Stage III Colon Cancer Trial in Sutton (Avelumab)

Terminated
  • POLE Exonuclease Mutant Colon Cancer
  • +2 more
  • Sutton, Surrey, United Kingdom
    Royal Marsden NHS Foundation Trust
Oct 5, 2022

Cohort of Tumors With POLE/D1 Mutation

Recruiting
  • Tumors
  • +2 more
    • Toulouse, France
      CHU -hopital Rangeuil
    Oct 22, 2021

    Endometrial Cancer Trial in Worldwide (drug, radiation, other)

    Recruiting
    • Endometrial Cancer
    • Toronto, Canada
    • +5 more
    Jul 12, 2022

    Kidney Stone Trial in Lahore (Mini-PCNL, RIRS)

    Completed
    • Kidney Stone
    • Mini-PCNL
    • RIRS
    • Lahore, Punjab, Pakistan
      Shaikh Zayed Hospital Lahore
    Jan 26, 2023

    Bone Atrophy, Alveolar Trial in Cairo (tent pole technique, Autogenous bone block technique)

    Recruiting
    • Bone Atrophy, Alveolar
    • tent pole technique
    • Autogenous bone block technique
    • Cairo, Egypt
      Cairo University
    Nov 5, 2023

    Endometrial Cancer Trial (Vaginal brachytherapy, Adjuvant radiotherapy (EBRT +/- brachytherapy), Observation)

    Not yet recruiting
    • Endometrial Cancer
    • Vaginal brachytherapy
    • +2 more
    • (no location specified)
    Nov 29, 2022

    A Retrospective Study on Multiple Classifier Endometrial Cancer

    Recruiting
    • Uterine Cancer
    • Observation only
    • Milan, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
    Jul 27, 2023

    Pole Walking Intervention in Retirement Communities

    Recruiting
    • Fall Injury
    • Osteoporotic Fractures
    • Pole Walking
    • Saskatoon, Saskatchewan, Canada
      Saija Kontulainen, University of Saskatchewan
    Aug 15, 2022

    Gastric, Colorectal Adenocarcinoma Trial in Shenyang (tislelizumab)

    Not yet recruiting
    • Gastric
    • Colorectal Adenocarcinoma
    • Shenyang, Liaoning, China
      Liaoning Cancer Hospital & Institute
    Nov 1, 2023

    Advance NSCLC Trial (GFH925, Cetuximab)

    Not yet recruiting
    • Advance Non-small Cell Lung Cancer
    • (no location specified)
    Mar 7, 2023

    Prognostic and Predictive Biomarkers in EGFR-mutant NSCLC

    Recruiting
    • Non-small Cell Lung Cancer
      • Guanzhou, China
        Sun Yat-sen University Cancer Center
      Aug 11, 2023

      NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC) Trial in San Antonio, Fairfax (RMC-9805)

      Recruiting
      • Non-small Cell Lung Cancer (NSCLC)
      • +3 more
      • San Antonio, Texas
      • +1 more
      Sep 8, 2023

      Low Grade Glioma of Brain Trial in Durham (PEPIDH1M vaccine + vorasidenib)

      Not yet recruiting
      • Low Grade Glioma of Brain
      • PEPIDH1M vaccine + vorasidenib
      • Durham, North Carolina
        Duke University Medical Center
      Nov 2, 2022

      First Line Treatment for BRAFV600E Mutant Metastatic Colorectal

      Completed
      • BRAF V600E Mutation Positive
      • Metastatic Colorectal Cancer
      • Non Interventional study
      • St. Veit/Glan, Austria
      • +33 more
      Jan 20, 2023

      Type2 Diabetes, Cognitive Impairment, Mild Trial in Kaohsiung (cognitive stimulation, as usual care)

      Completed
      • Type2 Diabetes Mellitus
      • Cognitive Impairment, Mild
      • cognitive stimulation
      • as usual care
      • Kaohsiung, Taiwan
        Yong-Kang Clinic
      Jun 8, 2023

      Renal Stones Trial in Kafr Ash Shaykh (lithotripsy using Flexible ureteroscope, extracorporeal shock wave lithotripsy (ESWL),

      Completed
      • Renal Stones
      • lithotripsy using Flexible ureteroscope
      • +2 more
      • Kafr Ash Shaykh, Egypt
        Kafrelsheikh University hospital
      Nov 6, 2023

      Metastatic Colorectal Cancer, mCRC Trial in Guangzhou (Tislelizumab & Fruquintinib)

      Not yet recruiting
      • Metastatic Colorectal Cancer
      • mCRC
      • Tislelizumab & Fruquintinib
      • Guangzhou, Guangdong, China
      • +1 more
      Jan 25, 2023

      Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

      Recruiting
      • Melanoma Stage III
      • Melanoma Stage IV
      • San Francisco, California
        University of California, San Francisco
      Dec 6, 2022

      H3 K27M, Glioma Trial in Santa Monica (ONC201, ONC201 + Placebo, Placebo)

      Recruiting
      • H3 K27M
      • Glioma
      • Santa Monica, California
        Providence Saint John's Cancer Institute
      Nov 28, 2022

      Advanced Solid Tumor Trial in Shanghai (SY-5933)

      Recruiting
      • Advanced Solid Tumor
      • Shanghai, China
        Shanghai Pulmonary Hospital
      Aug 16, 2023

      HER2-positive Metastatic Breast Cancer Trial in Aurora, Madison (Alpelisib, Tucatinib, Fulvestrant)

      Recruiting
      • HER2-positive Metastatic Breast Cancer
      • Aurora, Colorado
      • +2 more
      Dec 29, 2022

      NSCLC Trial in Singapore (Oral S-1 + Oral Osimertinib)

      Not yet recruiting
      • NSCLC
      • Oral S-1 + Oral Osimertinib
      • Singapore, Singapore
        National Cancer Center Singapore
      Mar 6, 2023

      Mild Cognitive Impairment, Alzheimer Trial in Chongqing (Computerized Cognitive Training, Treatment As Usual)

      Completed
      • Mild Cognitive Impairment
      • Alzheimer Disease
      • Computerized Cognitive Training
      • Treatment As Usual
      • Chongqing, Chongqing, China
        The First Affiliated Hospital of Chongqing Medical University
      Oct 19, 2023

      Lung Cancer Trial in Houston (Cemiplimab, Kevzara (Sarilumab))

      Not yet recruiting
      • Lung Cancer
      • Houston, Texas
        M D Anderson Cancer Center
      Jan 19, 2023

      Advanced NSCLC With KRAS G12C Mutation Trial in New York (Sotorasib, Ladarixin)

      Not yet recruiting
      • Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
      • New York, New York
        NYU Langone Health
      Apr 4, 2023